VIKING GLOBAL INVESTORS LP·SCHEDULE 13D/A

Feb 17, 8:46 PM ET

BridgeBio Pharma, Inc. SCHEDULE 13D/A

SCHEDULE 13D/A · VIKING GLOBAL INVESTORS LP · Filed Feb 17, 2026

Documents

3 files